MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.
Cataldo A, Piovan C, Plantamura I, D'Ippolito E, Camelliti S, Casalini P, Giussani M, Déas O, Cairo S, Judde JG, Tagliabue E, Iorio MV.
Cataldo A, et al.
Oncotarget. 2018 Jun 15;9(46):27920-27928. doi: 10.18632/oncotarget.24723. eCollection 2018 Jun 15.
Oncotarget. 2018.
PMID: 29963251
Free PMC article.